Tilmicosin was injected subcutaneously to lactating ewes once at a dose of
10 mg kg(-1) b.wt. to determine its plasma, milk, urine and ruminal juice c
oncentrations. Tilmicosin could be detected in all those fluids 30 minutes
after injection. Milk and urine concentrations were higher than those of pl
asma and ruminal juice. The drug was detectable in milk, urine and plasma f
or 9, 4 and 3 days after injection, respectively. No amount of tilmicosin c
ould be detected in ruminal juice 12 hours following administration. The me
an peak concentration of tilmicosin in plasma and milk (C-max) were 1.29 an
d 9.5 mu g ml(-1) and were obtained at (T-max) 5.235 and 15.093 hours, resp
ectively. The drug was slowly eliminated from plasma and milk as indicated
by its long half-life (t(1/2el)) of 15.4 and 26.2 hours, respectively.
The mean binding of tilmicosin to plasma and milk proteins in vitro was 16.
8 % and 26.8 %, respectively. The drug was not bound to ruminal juice at an
y extent. The rate of tilmicosin renal clearance revealed that it was corre
spondingly increased with higher blood concentrations. While creatinine cle
arance showed no significant change after tilmicosin administration. The ra
tio (fractional clearance) between tilmicosin renal clearance to creatinine
clearance was less than one indicating that the glomerular filtration is t
he main pathway of elimination through kidneys.
The rate of ruminal gas fermentation in ewes was inhibited after subcutaneo
us injection of tilmicosin at a dose of 10 mg kg(-1) b.wt. The tested sampl
es taken at different time intervals from the rumen of ewes showed a subseq
uent reduction in the rate of fermentation as compared to control samples.
The reduction was correspondingly increased with the increase of tilmicosin
concentration in ruminal juice and returned to normal thereafter.